WO1990006370A1
(en)
*
|
1988-12-01 |
1990-06-14 |
The Trustees Of The University Of North Carolina |
Synthetic interleukin-6
|
US5552391A
(en)
*
|
1990-01-16 |
1996-09-03 |
La Jolla Pharmaceutical Company |
Chemically-defined non-polymeric valency platform molecules and conjugates thereof
|
US20060084797A1
(en)
*
|
1990-06-11 |
2006-04-20 |
Gilead Sciences, Inc. |
High affinity TGFbeta nucleic acid ligands and inhibitors
|
US6465188B1
(en)
*
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5766897A
(en)
*
|
1990-06-21 |
1998-06-16 |
Incyte Pharmaceuticals, Inc. |
Cysteine-pegylated proteins
|
MX9304075A
(es)
*
|
1992-07-08 |
1994-04-29 |
Applied Research Systems |
Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos.
|
AU5098193A
(en)
*
|
1992-09-01 |
1994-03-29 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
ATE359830T1
(de)
*
|
1993-09-08 |
2007-05-15 |
Jolla Pharma |
Chemisch definierten nicht-polymer wertigen plattformmolokülen und ihren konjugaten
|
KR100361933B1
(ko)
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
US5795569A
(en)
*
|
1994-03-31 |
1998-08-18 |
Amgen Inc. |
Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
|
CZ288926B6
(cs)
*
|
1994-03-31 |
2001-09-12 |
Amgen Inc. |
MGDF derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
|
US20030053982A1
(en)
|
1994-09-26 |
2003-03-20 |
Kinstler Olaf B. |
N-terminally chemically modified protein compositions and methods
|
EP0785276A4
(en)
*
|
1994-09-29 |
2002-01-09 |
Ajinomoto Kk |
MODIFICATION OF A PEPTIDE AND A PROTEIN
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
US5770577A
(en)
*
|
1994-11-14 |
1998-06-23 |
Amgen Inc. |
BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
|
US8071737B2
(en)
*
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5874409A
(en)
|
1995-06-07 |
1999-02-23 |
La Jolla Pharmaceutical Company |
APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
|
US5861500A
(en)
*
|
1996-07-25 |
1999-01-19 |
The Trustees Of Columbia University In The City Of New York |
Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
|
US5854398A
(en)
*
|
1996-07-25 |
1998-12-29 |
The Trustees Of Columbia University In The City Of New York |
Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
|
CN1168495C
(zh)
*
|
1997-01-15 |
2004-09-29 |
凤凰药理学公司 |
被修饰的肿瘤坏死因子
|
US6183738B1
(en)
*
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
WO1999045026A1
(en)
|
1998-03-05 |
1999-09-10 |
Chiron Corporation |
Method for increasing the serum half-life of a biologically active molecule
|
US6887674B1
(en)
*
|
1998-04-13 |
2005-05-03 |
California Institute Of Technology |
Artery- and vein-specific proteins and uses therefor
|
US20030003545A1
(en)
*
|
1998-05-29 |
2003-01-02 |
Reinhard Ebner |
Interleukins-21 and 22
|
US6858210B1
(en)
|
1998-06-09 |
2005-02-22 |
La Jolla Pharmaceutical Co. |
Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
|
CN1329082C
(zh)
|
1998-10-16 |
2007-08-01 |
拜奥根Idec马萨诸塞公司 |
干扰素-β-1a的聚合物缀合物及其使用
|
TR200101087T2
(tr)
|
1998-10-16 |
2001-09-21 |
Biogen, Inc. |
İnterferon beta-füzyon proteinleri ve kullanımları
|
KR100719202B1
(ko)
|
1998-10-23 |
2007-05-16 |
키린-암젠 인코포레이티드 |
MPl 수용체에 결합하는 화합물 및 이를 함유하는 제약학적 조성물
|
US6399578B1
(en)
|
1998-12-09 |
2002-06-04 |
La Jolla Pharmaceutical Company |
Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
|
US6458953B1
(en)
|
1998-12-09 |
2002-10-01 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising carbamate linkages
|
EP1183230A1
(en)
*
|
1999-06-08 |
2002-03-06 |
La Jolla Pharmaceutical |
Valency platform molecules comprising aminooxy groups
|
US7135461B1
(en)
*
|
2000-06-16 |
2006-11-14 |
Myelos Corporation |
Retro-inverso peptides derived from interleukin-6
|
EP1270642B1
(en)
*
|
1999-12-24 |
2011-08-31 |
Kyowa Hakko Kirin Co., Ltd. |
Branched polyalkylene glycols
|
IT1317835B1
(it)
*
|
2000-02-15 |
2003-07-15 |
San Raffaele Centro Fond |
Citochine modificate per uso nella terapia del cancro.
|
JP2003535208A
(ja)
*
|
2000-06-08 |
2003-11-25 |
ラ ホヤ ファーマシューティカル カンパニー |
高分子量ポリエチレン・オキシドを含む多価プラットホーム分子
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
SK2772003A3
(en)
*
|
2000-09-08 |
2003-10-07 |
Gryphon Therapeutics Inc |
Synthetic erythropoiesis stimulating proteins
|
DE10059336A1
(de)
*
|
2000-11-29 |
2002-06-13 |
Scil Proteins Gmbh |
Herstellung von rekombinantem BMP-2
|
IL142875A
(en)
*
|
2001-04-30 |
2009-08-03 |
Avigdor Shafferman |
PEG-linked cholinesterases for the detoxification of circulating organophosphorus
|
ITMI20011986A1
(it)
*
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
GB0209896D0
(en)
|
2002-04-30 |
2002-06-05 |
Molmed Spa |
Conjugate
|
GB0209893D0
(en)
*
|
2002-04-30 |
2002-06-05 |
Molmed Spa |
Conjugate
|
AU2003243443B2
(en)
*
|
2002-06-21 |
2008-11-06 |
Centocor, Inc. |
Method for generating monoclonal antibodies
|
GEP20084487B
(en)
*
|
2002-12-26 |
2008-09-25 |
Mountain View Pharmaceuticals |
Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
|
MXPA05006994A
(es)
|
2002-12-27 |
2005-10-18 |
Diobex Inc |
Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina.
|
US7655618B2
(en)
|
2002-12-27 |
2010-02-02 |
Diobex, Inc. |
Compositions and methods for the prevention and control of insulin-induced hypoglycemia
|
US7553930B2
(en)
*
|
2003-01-06 |
2009-06-30 |
Xencor, Inc. |
BAFF variants and methods thereof
|
US20050221443A1
(en)
*
|
2003-01-06 |
2005-10-06 |
Xencor, Inc. |
Tumor necrosis factor super family agonists
|
US20050130892A1
(en)
*
|
2003-03-07 |
2005-06-16 |
Xencor, Inc. |
BAFF variants and methods thereof
|
US20060014248A1
(en)
*
|
2003-01-06 |
2006-01-19 |
Xencor, Inc. |
TNF super family members with altered immunogenicity
|
US7862816B2
(en)
|
2003-03-12 |
2011-01-04 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
US7381410B2
(en)
*
|
2003-03-12 |
2008-06-03 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
EP1491554A1
(en)
|
2003-06-23 |
2004-12-29 |
CONARIS research institute AG |
PEGylated soluble gp130-dimers useful as a medicament
|
IL159558A0
(en)
*
|
2003-12-24 |
2004-06-01 |
Applied Research Systems |
Use of il-6 in liver injury
|
WO2005085283A1
(ja)
*
|
2004-03-03 |
2005-09-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
修飾インターロイキン−11及びそれを含有する医薬組成物
|
CN102746401A
(zh)
|
2004-03-12 |
2012-10-24 |
瓦斯基因治疗公司 |
结合ephb4、抑制血管发生和肿瘤生长的抗体
|
CN101072797B
(zh)
|
2004-03-12 |
2012-05-09 |
瓦斯基因治疗公司 |
结合ephb4、抑制血管发生和肿瘤生长的抗体
|
US20050215710A1
(en)
*
|
2004-03-23 |
2005-09-29 |
Gegg Colin V Jr |
Chemically modified protein compositions and methods
|
US8143380B2
(en)
|
2004-07-08 |
2012-03-27 |
Amgen Inc. |
Therapeutic peptides
|
AU2005286662B2
(en)
*
|
2004-09-23 |
2011-10-06 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
CN101124243A
(zh)
|
2004-12-23 |
2008-02-13 |
莫尔梅德股份有限公司 |
缀合产物
|
CN101119743B
(zh)
|
2005-01-31 |
2012-09-26 |
株式会社Eci |
免疫增强剂
|
CN101163716B
(zh)
*
|
2005-04-30 |
2011-09-07 |
成都生物制品研究所 |
白细胞介素-6聚乙二醇结合物及其制备方法和应用
|
WO2007037795A2
(en)
|
2005-08-05 |
2007-04-05 |
Amgen Inc. |
Stable aqueous protein or antibody pharmaceutical formulations and their preparation
|
BRPI0618021A2
(pt)
*
|
2005-10-28 |
2011-08-16 |
Centocor Inc |
uso de agentes de expansão de célula b na geração de anticorpos
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
ES2352561T3
(es)
|
2006-06-30 |
2011-02-21 |
Conaris Research Institute Ag |
Dímeros de sgp 130fc mejorados.
|
TW200817438A
(en)
|
2006-08-17 |
2008-04-16 |
Hoffmann La Roche |
A conjugate of an antibody against CCR5 and an antifusogenic peptide
|
AR067537A1
(es)
*
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Purificacion de polipeptidos pegilados
|
AR067536A1
(es)
*
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
|
CL2008002092A1
(es)
|
2007-07-20 |
2009-05-29 |
Hoffmann La Roche |
Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
|
JP5735650B2
(ja)
|
2010-09-14 |
2015-06-17 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Peg化エリスロポエチンを精製するための方法
|
WO2013000872A2
(en)
*
|
2011-06-27 |
2013-01-03 |
Galderma Research & Development |
New th-17 differentiation markers for rosacea and uses thereof
|
MA41116A
(fr)
|
2014-12-01 |
2017-10-10 |
Ferring Bv |
Compositions d'inhibiteur de trans-signalisation par l'il-6 sélectif
|
US11198721B2
(en)
|
2014-12-01 |
2021-12-14 |
Ferring B.V. |
Methods for treatment of inflammatory disease or IL-6-mediated condition with gp130 protein
|
KR20220158870A
(ko)
|
2016-07-15 |
2022-12-01 |
에프. 호프만-라 로슈 아게 |
Peg화 에리트로포이에틴을 정제하기 위한 방법
|
TW202330584A
(zh)
*
|
2022-01-20 |
2023-08-01 |
丹麥商諾佛 儂迪克股份有限公司 |
前藥及其用途
|